CYP2A13 Antibody

Size : 100 µL Clone Number: Aliases: CP2AD_HUMAN antibody; CPAD antibody; CYP2A antibody; CYP2A13 antibody; CYPIIA13 antibody; Cytochrome P450 2A13 antibody; Cytochrome P450 family 2 subfamily A member 13 antibody; CYTOCHROME P450; SUBFAMILY IIA; POLYPEPTIDE 13 antibody Product Type: Polyclonal Antibody Immunogen Species: Homo sapiens (Human) UniProt ID: Q16696 Immunogen: Synthesized peptide derived from internal of Human Cytochrome P450 2A13. Host: Rabbit Reactivity: Human Tested Applications: ELISA, WB; WB: 1: 500-1: 3000 Background: Exhibits a coumarin 7-hydroxylase activity. Active in the metabolic activation of hexamethylphosphoramide, N,N-dimethylaniline, 2'-methoxyacetophenone, N-nitrosomethylphenylamine, and the tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Possesses phenacetin O-deethylation activity. Fernandez-Salguero P., Am. J. Hum. Genet. 57: 651-660(1995). Su T., cer Res. 60: 5074-5079(2000). Cauffiez C., m. Biophys. Res. Commun. 317: 662-669(2004). Clonality: Polyclonal Isotype: IgG Purification Method: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. Conjugate: Non-conjugated Buffer: Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Form: liquid Stroage: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze. Target Names: CYP2A13 Research Areas: Cancer Cardiovascular;Metabolism;Signal transduction